This inventor holds 1 USPTO granted patent. Top assignees: Kyowa Hakko Kogyo Co., Ltd., Kyowa Medex Co., Ltd., Tokai University. Active years: 2009.
Company Filing History:
1 out of 730 
1 out of 69 
1 out of 11 Years Active: 2009
Title: Tomomitsu Hotta: Innovator in Leukemia Diagnosis
Introduction
Tomomitsu Hotta is a notable inventor based in Nagoya, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the area of leukemia and related blood diseases. His innovative work has the potential to improve the accuracy of diagnoses and treatment options for patients.
Latest Patents
Tomomitsu Hotta holds a patent for a method of judging leukemia, pre-leukemia, or aleukemic malignant blood diseases. This patent, which is crucial for the medical community, outlines a method for diagnosing these conditions by quantifying stem cell growth factor (SCGF). The invention also includes methods for discriminating between various blood disorders and diagnosing complications related to hematopoietic stem cell transplantation.
Career Highlights
Throughout his career, Tomomitsu Hotta has worked with esteemed institutions such as Tokai University and Kyowa Medex Co., Ltd. His experience in these organizations has allowed him to collaborate with other professionals in the field and contribute to advancements in medical technology.
Collaborations
Tomomitsu has collaborated with notable colleagues, including Hidenao Sato and Kiyoshi Ando. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Tomomitsu Hotta's contributions to the field of leukemia diagnosis exemplify the impact of innovative thinking in medicine. His work not only enhances diagnostic methods but also paves the way for future advancements in the treatment of blood diseases.